|
FBXL14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.600500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.016800E-01 |
| Normal-vs-Stage2 |
3.543800E-03 |
| Normal-vs-Stage3 |
2.29309999999483E-05 |
| Normal-vs-Stage4 |
2.497300E-03 |
| Stage1-vs-Stage2 |
3.376400E-02 |
| Stage1-vs-Stage3 |
1.214020E-04 |
| Stage1-vs-Stage4 |
2.142300E-02 |
| Stage2-vs-Stage3 |
6.261200E-01 |
| Stage2-vs-Stage4 |
8.818400E-01 |
| Stage3-vs-Stage4 |
4.566400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.357800E-04 |
| Normal-vs-AfricanAmerican |
8.430200E-01 |
| Normal-vs-Asian |
5.420400E-01 |
| Caucasian-vs-AfricanAmerican |
2.151700E-02 |
| Caucasian-vs-Asian |
1.311610E-01 |
| AfricanAmerican-vs-Asian |
5.806200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.399900E-04 |
| Normal-vs-Female |
7.508100E-02 |
| Male-vs-Female |
1.157030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.302300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.939700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.818600E-03 |
| Normal-vs-Age(81-100Yrs) |
6.410400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.920600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.664600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.014600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.578400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.674000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.916600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.012770E-01 |
| Normal-vs-Grade 2 |
8.948000E-02 |
| Normal-vs-Grade 3 |
7.845000E-04 |
| Normal-vs-Grade 4 |
1.343310E-03 |
| Grade 1-vs-Grade 2 |
2.036100E-02 |
| Grade 1-vs-Grade 3 |
7.636200E-03 |
| Grade 1-vs-Grade 4 |
2.339400E-03 |
| Grade 2-vs-Grade 3 |
3.771900E-02 |
| Grade 2-vs-Grade 4 |
3.193600E-02 |
| Grade 3-vs-Grade 4 |
6.498200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.393500E-02 |
| Normal-vs-ccB subtype |
4.244400E-04 |
| ccA subtype-vs-ccB subtype |
3.339800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.177790E-03 |
| Normal-vs-N1 |
2.836800E-01 |
| N0-vs-N1 |
6.059200E-01 |
|
|
